Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for Endovascular Thrombectomy After Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 124 participants.
Also called NCT07696208
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 124 participants
- Sponsor
- Registry
-
NCT07696208
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07696208. Randomized; double masking; primary purpose treatment. Start 2026-07-01 (anticipated); primary completion 2028-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for Endovascular Thrombectomy After Ischemic Stroke
- Condition
- Hemodynamic Stability
- Condition
- Ischemic Strokes
- Intervention (Drug)
- Ciprofol
- Intervention (Drug)
- Propofol
- Lead sponsor
- RenJi Hospital
- Collaborator
- Haisco Pharmaceutical Group Co., Ltd.
Record details
- Record id
cardio:ct-nct07696208- Content hash
20bad0c7f5107c55ce8ebc325a1be1196d54a04d909c5683d8fec8bbe616e58b